Effects of a novel antitumor depsipeptide, FR901228, on human breast cancer cells

Breast Cancer Research and Treatment

Volumn 51, Issue 1, 1998, Pages 29-38

  Rajgolikar, Girish ^a   Chan, Kenneth K ^a   Wang, Hwa Chain R ^a,b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

^c UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Anticancer agent; Apoptosis; Breast cancer cells; FR901228; Intracellular signaling pathways

Indexed keywords

ANTINEOPLASTIC AGENT; DEPSIPEPTIDE; DNA; FR 901228; MYELIN BASIC PROTEIN; PROTEIN BCL 2; PROTEIN KINASE; PROTEIN P21; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE S PHASE; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA DEGRADATION; DRUG CYTOTOXICITY; ENZYME ACTIVATION; ENZYME ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DEPSIPEPTIDES; DNA, NEOPLASM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INDUCTION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PEPTIDES, CYCLIC; PHOSPHORYLATION; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0031768386     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006091014092     Document Type: Article

References (40)

1. Berg JW, Hutter RV: Breast cancer. Cancer Suppl 75: 257-269, 1994
2. Mackay J, Thompson AM, Cols C, Steel CM: Molecular lesions in breast cancer. Int J Cancer Suppl 5: 47-50, 1990
3. Callahan R, Cropp CS, Merlo GR, Liscia DS, Cappa APM, Lidereau R: Somatic mutations of human breast cancer. Cancer Suppl 69: 1582-1588, 1992
4. Cornelisse CJ, Cornelis RS, Devilee P: Gene responsible for familial breast cancer. Pathol Res Practice 192: 684-693, 1996
5. Eyfjord JE, Thorlacius S, Steinarsdottir M, Valgardsdottir R, Ogmundsdottir HM, Anamthawat-Jonsson K: P53 abnormalities and genomic instability in primary human breast carcinomas. Cancer Res 55: 646-651, 1995
6. Sierra A, Lloveras B, Castellsague X, Moreno L, Garcia-Ramirez M, Fabra A: Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma. Int J Cancer 60: 54-60, 1995
7. Ellis RE, Yuan J, Horvitz HR: Mechanisms and functions of cell death. Annu Rev Cell Biol 7: 663-698, 1991
8. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972
9. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555-556, 1980
10. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, Sturgill T Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262: 1065-1069, 1993
11. Cook SJ, McCormick F: Inhibition by cAMP of Ras-dependent activation of Raf. Science 262: 1069-1072, 1993
12. Fath I, Schwighoffer F, Rev I, Multon MC, Boiziau J, Duchesne M, Tocque' B: Cloning of a Grb2 isoform with apoptotic properties. Science 264: 971-974, 1994
13. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR: The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369: 156-160, 1994
14. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing effects of Erk and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331, 1995
15. Chen Y-R, Wang X, Meyer CF, Tan T-H: The role of JNK in apoptosis: Duration of JNK activation may determine cell death and proliferation. J Biol Chem 271: 31929-31936, 1996
16. Haldar S, Jena N, Croce CM: Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92: 4507-4511, 1995
17. Haldar S, Basu A, Croce CM: Bcl-2 is the guardian of microtubule integrity. Cancer Res 57: 229-233, 1997
18. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y: WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54: 1169-1174, 1994
19. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 88: 323-331, 1997
20. Moore J, Boswell S, Hoffman R, Burgess G, Hromas R: Mutant H-ras overexpression inhibits a random apoptotic nuclease in myeloid leukemia cells. Leuk Res 17: 703-709, 1993
21. Ueda H, Nakajima H, Hori Y, Fujita T, Nishimura M, Goto T, Okuhara M: FR901228, a novel antitumor bicyclic depsipeptide produced by Chromabacterium violaceum No. 968: I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity. J Antibiotics 47: 301-310, 1994
22. Ueda H, Manda R, Matsumoto S, Nishigaki F, Kawamura J, Shimomura K: FR901228, a novel antitumor bicylic depsipeptide produced by Chromabacterium violaceum No. 968: III. Antitumor activities on experimental tumors in mice. J Antibiotics 47: 315-323, 1994
23. Ueda H, Nakajima H, Hori Y, Goto T, Okuhara M: Action of FR901228, a novel antitumor bicyclic depsipepetide produced by Chromabacterium violaceum No. 968. on Ha-ras transformed NIH3T3 cells. Biosci Biotech Biochem 58: 1579-1583, 1994
24. Gilbert NE, O'Reilly JE, Chang CJG, Lin YC, Brueggemeier RW: Antiproliferative activity of gossypol and gossypolone on human breast cancer cells. Life Sci 75: 61-67, 1995
25. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W: Current Protocols in Immunology. NIH, 1993, Vol. 2: A.3.3
26. nd Ed. Part A. 1995, pp 32-36
27. SAMK in chicken embryo fibroblast at the late stage of src-induced cellular transformation. J Cell Physiol 168: 87-96, 1996
28. Lowe SW, Ruley HE, Jacks T, Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967, 1993
29. Levenson AS, Jordan VC: MCF-7: The first hormone-responsive breast cancer cell line. Cancer Res 57: 3071-3078, 1997
30. Negrini M, Sabbioni S, Haldar S, Possati L, Castagnoli A, Corallini A, Barbanti-Brodano G, Croce CM: Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions. Cancer Res 54: 1818-1824, 1994
31. Bertrand R, Solary E, O'Connor P, Kohn KW, Pommier Y: Induction of a common pathway of apoptosis by staurosporine. Exp Cell Res 211: 314-321, 1994
32. Sheikh MS, Li S, Chen JC, Shao ZM, Ordonez JV, Fontana JA: Mechanisms of regulation of WAF1/Cip1 gene expression of human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene 9: 3407-3415, 1994
33. Ichijo H, Nishida E, Irie K, Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, Gotoh Y: Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275: 90-94, 1997
34. Meyer CF, Wang X, Chang C, Templeton D, Tan T-H: Interaction between c-Rel and the mitogen-activated protein kinase kinase kinase 1 signaling cascade in mediating kB enhancer activation. J Biol Them 271: 8971-8976, 1996
35. Minden A, Lin A, McMahon M, Lange-Carter C, Derijard B, Davis RJ, Johnson GL, Karin M: Differential activation of Erk and JNK mitogen-activated protein kinases by Raf-1 and Mekk. Science 266: 1719-1723, 1994
36. Lin A, Minden A, Martinetto H, Claret F-X, Lange-Charter C, Mercurio F, Johnson GL, Karin M: Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science 268: 286-290, 1995
37. Shao ZM, Dawson MI, Li XS, Rishi AK, Sheikh MS, Han QX, Ordonex JV, Shroot B, Fontana JA: p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene 11: 493-504, 1995
38. Lu ML, Sato M, Cao B, Richie JP: UV irradiation-induced apoptosis leads to activation of a 36-kDa myelin basic protein kinase in HL-60 cells. Proc Natl Acad Sci US A 93: 8977-8982, 1996
39. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81: 323-330, 1995
40. Sherr C, Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9: 1149-1163, 1995